FORM N-PX PROXY VOTING RECORD
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | COLUMN 9 | COLUMN 10 | COLUMN 11 | COLUMN 12 | COLUMN 13 | COLUMN 14 | COLUMN 15 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NAME OF ISSUER |
CUSIP | ISIN | FIGI | MEETING DATE | VOTE DESCRIPTION | VOTE CATEGORY | DESCRIPTION OF OTHER CATEGORY | VOTE SOURCE | SHARES VOTED | SHARES ON LOAN | DETAILS OF VOTE | MANAGER NUMBER | SERIES ID | OTHER INFO | ||
HOW VOTED | SHARES VOTED | FOR OR AGAINST MANAGEMENT | ||||||||||||||
AKERO THERAPEUTICS INC | 00973Y108 | - | - | 06/07/2024 | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers; | SECTION 14A SAY-ON-PAY VOTES |
- | - | 5233989 | 0 | FOR |
5233989 |
FOR |
- | - | |
ALIGNMENT HEALTHCARE INC | 01625V104 | - | - | 06/07/2024 | Approval, on a non-binding, advisory basis, of the compensation of our named executive officers ("Named Executive Officers" or "NEOs"). | SECTION 14A SAY-ON-PAY VOTES |
- | - | 55803328 | 0 | FOR |
55803328 |
FOR |
- | - | |
SQUARESPACE INC | 85225A107 | - | - | 06/04/2024 | To approve by a non-binding advisory vote the frequency of future advisory votes to approve the compensation of our named executive officers; | SECTION 14A SAY-ON-PAY VOTES |
- | - | 5542966 | 0 | FOR |
5542966 |
FOR |
- | - | |
CONTEXTLOGIC INC | 21077C305 | - | - | 04/12/2024 | A proposal to approve, on an advisory, non-binding basis, certain compensation that has, will or may be paid or become payable to the Company's named executive officers in connection with the Asset Sale (the "Advisory Compensation Proposal"); and | SECTION 14A SAY-ON-PAY VOTES |
- | - | 609616 | 0 | FOR |
609616 |
FOR |
- | - | |
CONTEXTLOGIC INC | 21077C305 | - | - | 06/18/2024 | To approve, on an advisory basis, our named executive officer compensation for the year ended December 31, 2023, as disclosed herein. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 0 | 0 | NO VOTE CAST |
0 |
AGAINST |
- | - | |
IMMUNOCORE HLDGS PLC | 45258D105 | - | - | 05/23/2024 | To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the attached proxy statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1506684 | 0 | FOR |
1506684 |
FOR |
- | - | |
IMMUNOCORE HLDGS PLC | 45258D105 | - | - | 05/23/2024 | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1506684 | 0 | FOR |
1506684 |
FOR |
- | - | |
KARUNA THERAPEUTICS, INC. | 48576A100 | - | - | 03/12/2024 | To consider and vote on a proposal to approve, on a non-binding, advisory basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger (the "named executive officer merger-related compensation proposal"); | SECTION 14A SAY-ON-PAY VOTES |
- | - | 986710 | 0 | FOR |
986710 |
FOR |
- | - | |
MOBILEYE GLOBAL INC | 60741F104 | - | - | 06/13/2024 | Advisory vote on executive compensation | SECTION 14A SAY-ON-PAY VOTES |
- | - | 1194839 | 0 | FOR |
1194839 |
FOR |
- | - | |
OPENDOOR TECHNOLOGIES INC | 683712103 | - | - | 06/14/2024 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers, as disclosed in the accompanying proxy statement. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 6321519 | 0 | FOR |
6321519 |
FOR |
- | - | |
ROYALTY PHARMA PLC | G7709Q104 | - | - | 06/06/2024 | Approve on a non-binding advisory basis the compensation of our named executive officers. | SECTION 14A SAY-ON-PAY VOTES |
- | - | 2055039 | 0 | FOR |
2055039 |
FOR |
- | - | |
SQUARESPACE INC | 85225A107 | - | - | 06/04/2024 | To approve by a non-binding advisory vote the compensation of our named executive officers, as disclosed in this proxy statement; | SECTION 14A SAY-ON-PAY VOTES |
- | - | 5542966 | 0 | FOR |
5542966 |
FOR |
- | - |
[Repeat as Necessary]